These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 26374685)

  • 1. Oversight on the borderline: Quality improvement and pragmatic research.
    Finkelstein JA; Brickman AL; Capron A; Ford DE; Gombosev A; Greene SM; Iafrate RP; Kolaczkowski L; Pallin SC; Pletcher MJ; Staman KL; Vazquez MA; Sugarman J
    Clin Trials; 2015 Oct; 12(5):457-66. PubMed ID: 26374685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The views of quality improvement professionals and comparative effectiveness researchers on ethics, IRBs, and oversight.
    Whicher D; Kass N; Saghai Y; Faden R; Tunis S; Pronovost P
    J Empir Res Hum Res Ethics; 2015 Apr; 10(2):132-44. PubMed ID: 25742674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harmonization and streamlining of research oversight for pragmatic clinical trials.
    O'Rourke PP; Carrithers J; Patrick-Lake B; Rice TW; Corsmo J; Hart R; Drezner MK; Lantos JD
    Clin Trials; 2015 Oct; 12(5):449-56. PubMed ID: 26374678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. American Society of Clinical Oncology policy statement: oversight of clinical research.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Considerations in the evaluation and determination of minimal risk in pragmatic clinical trials.
    Lantos JD; Wendler D; Septimus E; Wahba S; Madigan R; Bliss G
    Clin Trials; 2015 Oct; 12(5):485-93. PubMed ID: 26374686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethical oversight in quality improvement and quality improvement research: new approaches to promote a learning health care system.
    Fiscella K; Tobin JN; Carroll JK; He H; Ogedegbe G
    BMC Med Ethics; 2015 Sep; 16(1):63. PubMed ID: 26383770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the ethical and regulatory issues in pragmatic clinical trials.
    Califf RM; Sugarman J
    Clin Trials; 2015 Oct; 12(5):436-41. PubMed ID: 26374676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stepped-wedge trials should be classified as research for the purpose of ethical review.
    Hemming K; Taljaard M; Marshall T; Goldstein CE; Weijer C
    Clin Trials; 2019 Dec; 16(6):580-588. PubMed ID: 31818147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-based interventions for neurologic conditions: ethical challenges for early human trials.
    Mathews DJ; Sugarman J; Bok H; Blass DM; Coyle JT; Duggan P; Finkel J; Greely HT; Hillis A; Hoke A; Johnson R; Johnston M; Kahn J; Kerr D; Kurtzberg J; Liao SM; McDonald JW; McKhann G; Nelson KB; Rao M; Regenberg A; Siegel AW; Smith K; Solter D; Song H; Vescovi A; Young W; Gearhart JD; Faden R
    Neurology; 2008 Jul; 71(4):288-93. PubMed ID: 18463365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethical responsibilities toward indirect and collateral participants in pragmatic clinical trials.
    Smalley JB; Merritt MW; Al-Khatib SM; McCall D; Staman KL; Stepnowsky C
    Clin Trials; 2015 Oct; 12(5):476-84. PubMed ID: 26374687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gatekeepers for pragmatic clinical trials.
    Whicher DM; Miller JE; Dunham KM; Joffe S
    Clin Trials; 2015 Oct; 12(5):442-8. PubMed ID: 26374683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adrift in the Gray Zone: IRB Perspectives on Research in the Learning Health System.
    Lee SS; Kelley M; Cho MK; Kraft SA; James C; Constantine M; Meyer AN; Diekema D; Capron AM; Wilfond BS; Magnus D
    AJOB Empir Bioeth; 2016; 7(2):125-134. PubMed ID: 27917391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ethical oversight of learning health care activities in Switzerland: a qualitative study.
    McLennan S
    Int J Qual Health Care; 2019 Oct; 31(8):G81-G86. PubMed ID: 31066452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethical and regulatory issues of pragmatic cluster randomized trials in contemporary health systems.
    Anderson ML; Califf RM; Sugarman J;
    Clin Trials; 2015 Jun; 12(3):276-86. PubMed ID: 25733677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enough is enough … a call to action to improve ethical and governance review processes in Australia.
    Evans SM; Zalcberg JR
    Intern Med J; 2016 Dec; 46(12):1362-1364. PubMed ID: 27981777
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulatory and ethical considerations for linking clinical and administrative databases.
    Dokholyan RS; Muhlbaier LH; Falletta JM; Jacobs JP; Shahian D; Haan CK; Peterson ED
    Am Heart J; 2009 Jun; 157(6):971-82. PubMed ID: 19464406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the quality of human research protection programs to improve protection of human subjects participating in clinical trials.
    Tsan MF; Tsan LW
    Clin Trials; 2015 Jun; 12(3):224-31. PubMed ID: 25631384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harms, benefits, and the nature of interventions in pragmatic clinical trials.
    Ali J; Andrews JE; Somkin CP; Rabinovich CE
    Clin Trials; 2015 Oct; 12(5):467-75. PubMed ID: 26374680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ensuring participant safety and trial integrity with clinical trials oversight.
    Godfrey C; Payton M; Tasker S; Proestel S; Schouten JT
    J Acquir Immune Defic Syndr; 2014 Jan; 65 Suppl 1(0 1):S40-3. PubMed ID: 24321985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality, safety, and institutional review boards: navigating ethics and oversight in applied health systems research.
    Kass NE; Pronovost PJ
    Am J Med Qual; 2011; 26(2):157-9. PubMed ID: 21403179
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.